NCT02861300 2024-12-19CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal CancerCase Comprehensive Cancer CenterPhase 1/2 Completed50 enrolled 16 charts